Enlightenment Research’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-4,450
Closed -$789K 143
2022
Q1
$789K Buy
+4,450
New +$757K 1.05% 24
2021
Q4
Sell
-1,400
Closed -$226K 170
2021
Q3
$226K Buy
+1,400
New +$239K 0.28% 114
2020
Q3
Sell
-5,900
Closed -$830K 95
2020
Q2
$830K Buy
+5,900
New +$860K 1.98% 11
2020
Q1
Sell
-3,900
Closed -$569K 178
2019
Q4
$569K Buy
+3,900
New +$529K 2.67% 8
2019
Q3
Sell
-19,600
Closed -$2.74M 185
2019
Q2
$2.74M Buy
19,600
+17,698
+930% +$2.45M 1.39% 9
2019
Q1
$266K Buy
+1,902
New +$255K 0.52% 62

Other funds holding JNJ

Enlightenment Research's JNJ Position: Q2 2022 in Review

Enlightenment Research sold out of Johnson & Johnson (JNJ) in Q2 2022, closing a stake of 4,450 shares — an estimated $789K sold.

Enlightenment Research first reported a position in JNJ in Q1 2019 and held it in 6 quarters. The position peaked at $2.74M in Q2 2019. 3,672 funds tracked by Wall St. Rank hold JNJ as of Q2 2022.

  • Enlightenment Research reported no remaining Johnson & Johnson position as of Q2 2022 after selling out during the quarter.
  • Enlightenment Research sold 4,450 Johnson & Johnson shares in Q2 2022, an estimated $789K.
  • Enlightenment Research first reported a position in Johnson & Johnson in Q1 2019 and held it in 6 quarters.
  • Enlightenment Research's Johnson & Johnson position peaked at $2.74M in Q2 2019.
  • 3,672 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2022.

Based on Enlightenment Research's 13F filing for Q2 2022, filed 12 Aug 2022.